Insight Molecular Diagnostics Inc.
IMDX
$5.34
-$0.18-3.17%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -11.41% | -46.04% | 80.09% | -148.36% | -197.86% |
| Total Depreciation and Amortization | 4.47% | 13.85% | -12.79% | 65.59% | 4.29% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 21.44% | 147.58% | -95.25% | 276.69% | 1,382.86% |
| Change in Net Operating Assets | 447.49% | 54.21% | 9.92% | -11,490.00% | 99.15% |
| Cash from Operations | 28.30% | -7.19% | -9.41% | 3.18% | 7.49% |
| Capital Expenditure | -200.86% | -13.68% | -43.46% | -145.98% | 54.45% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -200.86% | -13.68% | -46.19% | -141.38% | 54.45% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -5.26% | -16.33% | -19.51% | 4.65% | -160.61% |
| Issuance of Common Stock | -- | -100.00% | 143.08% | 66,505.56% | -99.89% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | 100.00% |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | 54.49% | -472.19% | 65.24% |
| Cash from Financing | -5.26% | -100.40% | 163.52% | 4,349.80% | -102.59% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 14.31% | -130.11% | 324.67% | 189.48% | -260.22% |